1. Home
  2. Analysis
  3. Willow-bark
  4. Potassium

Willow bark and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Willow bark (willow bark) and Potassium (potassium). Common drug interactions include asthenia among females.

The phase IV clinical study analyzes what interactions people have when they take Willow bark and Potassium. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Willow bark?

Willow bark has active ingredients of willow bark. eHealthMe is studying from 58 Willow bark users. Check the latest studies of Willow bark.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

On Aug, 07, 2026

13 people who take Willow bark and Potassium together, and have interactions are studied.

Willow bark and Potassium drug interactions.

What are the common drug interactions of Willow Bark and Potassium, by gender? *:

female:

  1. Asthenia (weakness)
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness)
  3. Acne (skin problems that cause pimples)
  4. Alopecia (absence of hair from areas of the body)
  5. Anxiety
  6. Bone deformity
  7. Cerebral vasoconstriction (constriction of brain blood vessels)
  8. Depression
  9. Dizziness
  10. Drug ineffective

male:

n/a

What are the common drug interactions of Willow Bark and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 92.31%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 76.92%
  3. Stress And Anxiety: 1 person, 7.69%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.69%
  5. Asthma: 1 person, 7.69%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 7.69%
  7. Blood Potassium Decreased: 1 person, 7.69%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
  9. Constipation: 1 person, 7.69%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Willow bark and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Willow bark and Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Willow bark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Willow bark and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on willow bark and potassium (the active ingredients of Willow bark and Potassium, respectively), and Willow bark and Potassium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.